Harirak WanmuangJuvady LeopairutChomsri KositchaiwatWinai WananukulSukhum BunyaratvejMahidol UniversityFaculty of Medicine, Ramathibodi Hospital, Mahidol University2018-08-242018-08-242007-01-01Journal of the Medical Association of Thailand. Vol.90, No.1 (2007), 179-18101252208012522082-s2.0-33847002316https://repository.li.mahidol.ac.th/handle/20.500.14594/25047Hepatotoxic effect related to Ganoderma lucidum (Lingzhi) mushroom powder was first described in a patient from Hong Kong in 2004. In 2005, the authors experienced a case of fatal fulminant hepatitis associated with such a preparation. Both patients had taken other therapeutic agents and traditionally boiled Lingzhi without any toxic effect. After switching to taking Lingzhi in powder form for 1-2 months, the hepatotoxic episode occurred in both patients. The toxic role of Lingzhi powder needs close monitoring in the future, especially in combination with other drugs.Mahidol UniversityMedicineArticleSCOPUS